Medical Pharmacology, PCTX 610, 1995
G.L. Coppoc, DVM, PhD
(Copyright 1995 by Purdue Research Foundation. All rights
reserved.)
Return to -- (Syllabi) (Overview)
Return to -- (Syllabi) (Overview
Return to -- (Syllabi) (Overview)
Return to -- (Syllabi) (Overview) (Why Need & General PR Menu)
Return to -- (Syllabi) (Overview) (Why Need & General PR Menu)
Syllabi) (Overview) (Why Need & General PR Menu)
Syllabi) (Overview) (Why Need & General PR Menu)
Return to -- (Syllabi) (Overview) (Why Need & General PR Menu)
Return to -- (Syllabi) (Overview) (Why Need & General PR Menu)
Return to -- (Syllabi) (Overview) (Why Need & General PR Menu)
Syllabi) (Overview) (Important Pkin Variables Menu)
Syllabi) (Overview) (Important Pkin Variables Menu)
Syllabi) (Overview) (Important Pkin Variables Menu)
Virtual volume, of fluid in which concentration is measured (PLASMA?), required to explain the dilution of drug injected into the body
Return to -- (Syllabi) (Overview) (Important Pkin Variables Menu) (Vd Start)
Return to -- (Syllabi) (Overview) (Important Pkin Variables Menu) (Vd Start)
Return to -- (Syllabi) (Overview) (Important Pkin Variables Menu) (Vd Start)
Return to -- (Syllabi) (Overview) (Important Pkin Variables Menu) (Vd Start)
Return to -- (Syllabi) (Overview) (Important Pkin Variables Menu) (Vd Start) (Clearance Start)
Return to -- (Syllabi) (Overview) (Important Pkin Variables Menu) (Clearance Start)
Return to -- (Syllabi) (Overview) (Important Pkin Variables Menu) (Clearance Start)
Ke = Fraction of Vd cleansed of drug per unit time and Fraction of drug removed per unit time (not shown here!) (e.g., frcn/hr )
Return to -- (Syllabi) (Overview) (Important Pkin Variables Menu) (Clearance Start)
Return to -- (Syllabi) (Overview) (Important Pkin Variables Menu) (Clearance Start)
Return to -- (Syllabi) (Overview) (Important Pkin Variables Menu) (Clearance Start)
Return to -- (Syllabi) (Overview) (Important Pkin Variables Menu) (Bioavailability Start)
Syllabi) (Overview) (Important Pkin Variables Menu) (Bioavailability Start)
Return to -- (Syllabi) (Overview) (Bioavailability Start)
Syllabi) (Overview) (Constant Infusion Start)
Return to -- (Syllabi) (Overview) (Constant Infusion Start)
Return to -- (Syllabi) (Overview) (Constant Infusion Start)
Note: CL predicted by population (literature) was 0.33 L/hr, slower than found in this patient, therefore, had to adjust dose to higher amount
Return to -- (Syllabi) (Overview) (Constant Infusion Start)
Return to -- (Syllabi) (Overview) (Constant Infusion Start)
Return to -- (Syllabi) (Overview) (Constant Infusion Start)
Return to -- (Syllabi) (Overview) (Constant Infusion Start)
Return to -- (Syllabi) (Overview) (Constant Infusion Start) (Bolus / Multidose Start)
Return to -- (Syllabi) (Overview) (Constant Infusion Start) (Bolus / Multidose Start)
Return to -- (Syllabi) (Overview) (Constant Infusion Start) (Bolus / Multidose Start)
Return to -- (Syllabi) (Overview) (Constant Infusion Start) (Bolus / Multidose Start) (1-COM Start)
Return to -- (Syllabi) (Overview) (Constant Infusion Start) (Bolus / Multidose Start) (1-COM Start)
Return to -- (Syllabi) (Overview) (Constant Infusion Start) (Bolus / Multidose Start) (1-COM Start)
Return to -- (Syllabi) (Overview) (Constant Infusion Start) (Bolus / Multidose Start) (1-COM Start)
Return to -- (Syllabi) (Overview) (Constant Infusion Start) (Bolus / Multidose Start) (1-COM Start) (2-COM Start)
Return to -- (Syllabi) (Overview) (Constant Infusion Start) (Bolus / Multidose Start) (1-COM Start) (2-COM Start)
Return to -- (Syllabi) (Overview) (Constant Infusion Start) (Bolus / Multidose Start) (1-COM Start) (2-COM Start)
Return to -- (Syllabi) (Overview) (Constant Infusion Start) (Bolus / Multidose Start) (1-COM Start) (2-COM Start)
Return to -- (Syllabi) (Overview) (Constant Infusion Start) (Bolus / Multidose Start) (multi-dose)
Css(ave)=(FD/T) * [1 / (Ke * Vd)]
Return to -- (Syllabi) (Overview) (Constant Infusion Start) (Bolus / Multidose Start) (multi-dose)
Return to -- (Syllabi) (Overview) (Constant Infusion Start) (Bolus / Multidose Start) (multi-dose)
Return to -- (Syllabi) (Overview) (Constant Infusion Start) (Bolus / Multidose Start) (multi-dose)
Return to -- (Syllabi) (Overview) (Constant Infusion Start) (Bolus / Multidose Start) (multi-dose)
Return to -- (Syllabi) (Overview) (Constant Infusion Start) (Bolus / Multidose Start) (multi-dose)
Return to -- (Syllabi) (Overview) (Constant Infusion Start) (Bolus / Multidose Start) (multi-dose)
Return to -- (Syllabi) (Overview) (Constant Infusion Start) (Bolus / Multidose Start) (multi-dose)
Know CL, but not
half-life. Measure conc.
after stopping infusion
that produced 15 mg/L.
Conc = 12 mg/L 4 hr after
stop.
Half-life = _______ hr;
Ke = _______/hr
Return to -- (Syllabi) (Overview) (Constant Infusion Start) (Bolus / Multidose Start) (multi-dose) (Sample calculation start)
Return to -- (Syllabi) (Overview) (Constant Infusion Start) (Bolus / Multidose Start) (multi-dose) (Sample calculation start)
Return to -- (Syllabi) (Overview) (Constant Infusion Start) (Bolus / Multidose Start) (multi-dose) (Sample calculation start)
Return to -- (Syllabi) (Overview) (Constant Infusion Start) (Bolus / Multidose Start) (multi-dose) (Sample calculation start)
index | lecture menu |
Send
suggestions / questions
Last modified: 8/18/96
glc